Inovio wins prestigious Edward Jenner Poster Award for cervical cancer vaccine research

Inovio Pharmaceuticals (AMEX:INO) won the Edward Jenner Poster Award First Prize for its research to develop a therapeutic, synthetic vaccine for cancer.

Read more »

NanoViricides Reports Positive Anti-viral Effect of HIV Drug

NanoViricides’ anti-HIV drug candidate, HIVCide, achieved a positive, long-term effect with fewer and weaker doses than the traditional anti-retroviral combination therapy.

Read more »

Bacterin Receives $15 Million Credit Facility

Bacterin International Holdings (AMEX:BONE) announced Tuesday it secured a 42 month-long, $15 million credit facility with MidCap Financial LLC and Silicon Valley Bank.

Read more »

IntelliCell BioSciences To Open Adipose Tissue Processing Center in Houston

IntelliCell BioSciences, Inc. (OTCQB: SVFC), maker of stromal vascular fraction that contains adipose derived adult stem cells opens new processing center in Houston, Texas.

Read more »

Bio-Rad receives pre-market approval for HIV test from FDA

Bio-Rad Laboratories (NYSE:BIO) announced Monday it received FDA premarket approval for its fourth generation human immunodeficiency virus (HIV) diagnostic test.

Read more »

Drug maker GlaxoSmithKline receives upbeat results in Promacta phase three study

Biotech company Ligand Pharmaceuticals Inc. reported Tuesday that its partner GlaxoSmithKline received encouraging results in Hepatitis C study.

Read more »

E-Therapeutics expects to generate a “wealth of data” from clinical trials

E-Therapeutics (LON:ETX) expects to generate a “wealth of data” from a clinical programme focusing on four drug candidates.

Read more »

Novartis’ NVA237 improves lung function in pulmonary disease patients

Swiss drug maker Novartis said results from a phase three study remarkably improved lung function in a similar way to a rival drug.

Read more »

Inherent value to be “developed and extracted” at Amphion

Amphion Innovations (LON:AMP) said it believes there is “significant inherent value to be developed and extracted” from its partner companies, […]

Read more »

Neostem’s Suzhou Eyre receives Chinese Regulatory Approval For 6th Production Line

NeoStem announced Monday that its subsidiary, Suzhou Eyre Pharmaceuticals, has received approval for its sixth production line.

Read more »